Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Qiagen NV - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
QGEN
New York
2836
https://www.qiagen.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Qiagen NV
QIAGEN (QGEN) Unveils QIAstat-Dx Analyzer With Remote Access
- Mar 26th, 2024 2:07 pm
QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system
- Mar 25th, 2024 8:05 pm
QIAGEN (QGEN) Partners With IPPA to Raise TB Screening Awareness
- Mar 25th, 2024 1:10 pm
Labcorp (LH) Boost Diagnostics Suite With New Biomarker Test
- Mar 25th, 2024 11:03 am
Has Qiagen N.V. (NYSE:QGEN) Stock's Recent Performance Got Anything to Do With Its Financial Health?
- Mar 21st, 2024 10:23 am
QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements
- Mar 18th, 2024 8:05 pm
Why Is Incyte (INCY) Up 1.8% Since Last Earnings Report?
- Mar 14th, 2024 3:30 pm
QIAGEN announces Form 20-F annual report filing for 2023 results
- Mar 11th, 2024 9:59 am
Qiagen (QGEN) Up 1.1% Since Last Earnings Report: Can It Continue?
- Mar 7th, 2024 4:31 pm
QIAGEN (QGEN) Launches AI-Driven Biomedical Knowledge Base
- Mar 4th, 2024 1:39 pm
Qiagen N.V. (NYSE:QGEN) is largely controlled by institutional shareholders who own 81% of the company
- Feb 29th, 2024 5:30 pm
QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery
- Feb 27th, 2024 10:44 pm
QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification
- Feb 27th, 2024 9:05 pm
QIAGEN (QGEN) Earns Notable Recognitions in Sustainability
- Feb 19th, 2024 2:09 pm
Qiagen N.V. (NYSE:QGEN) Q4 2023 Earnings Call Transcript
- Feb 13th, 2024 1:26 pm
The Qiagen N.V. (NYSE:QGEN) Full-Year Results Are Out And Analysts Have Published New Forecasts
- Feb 9th, 2024 10:41 am
QIAGEN (QGEN) Q4 Earnings Miss, Operating Margin Expands
- Feb 7th, 2024 12:20 pm
Qiagen (QGEN) Reports Q4 Earnings: What Key Metrics Have to Say
- Feb 7th, 2024 1:00 am
QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved operational profitability
- Feb 6th, 2024 9:05 pm
QIAGEN (QGEN) Forges Alliance to Advance Microbiome Sciences
- Jan 31st, 2024 12:35 pm
Scroll